Trial intelligence / Profile preview

Metformin prophylaxis for symptomatic YF17D infection

NCT04267809Phase 2Completed

Sponsor
Singapore General Hospital
Start
Oct 2021
Primary completion
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of metformin in yellow fever, sponsored by Singapore General Hospital. Started Oct 2021; status: completed.

02

Drugs

metformin
03

Conditions

yellow fever

Beyond the preview

Go deeper on NCT04267809.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04267809.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call